Patient Admitted to Intensive Care Unit for COVID-19
Conditions
Brief summary
Some patients admitted to intensive care for a severe form of COVID-19 could have respiratory, cardiac, renal and neurological sequelae in the medium or long term. The results of this research will allow an improvement in the understanding and management of patients in the medium and long term.
Interventions
OTHERFollow-up of patients with COVID-19
The presence of sequelae, number of re-hospitalizations, date of death and cost of health expenditure will be collected. The Quality of life score (SF-36 questionnaire) and the Pittsburgh sleep quality index (PSQI questionnaire) will be completed by patients.
Sponsors
University Hospital, Strasbourg, France
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient admitted to intensive care unit for COVID-19 * Adult patient ≥ 18 years old * Subject having expressed his non-opposition to the research * Subject affiliated to a social health insurance protection scheme or beneficiary of such a scheme
Exclusion criteria
* Subject under safeguard of justice * Patient under guardianship or curatorship
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The presence of respiratory, renal, cardiac, motor, neurological, and psychological sequelae will be assessed by specialist doctors during the 12 months following the patient's discharge from intensive care. | The primary endpoint will be measured during 12 months following the patient's discharge from intensive care. |
Secondary
| Measure | Time frame |
|---|---|
| 1) The sequelae by type of impairment will be assessed by specialist doctors at 3, 6 and 12 months | At M3 (+/-15 days) : 3 months after patient inclusion-At M6 (+/-15 days) : 6 months after patient inclusion-At M12 (+/-15 days) : 12 months after patient inclusion |
| 2) Number of re-hospitalizations at 3, 6 and 12 months | At M3 (+/-15 days) : 3 months after patient inclusion-At M6 (+/-15 days) : 6 months after patient inclusion-At M12 (+/-15 days) : 12 months after patient inclusion |
| 3) Date of death | Date of death will be collected from inclusion to M12 (12 months after patient inclusion) |
| 4.1) Quality of life score (SF-36 questionnaire) at 3, 6 and 12 months | At M3 (+/-15 days) : 3 months after patient inclusion-At M6 (+/-15 days) : 6 months after patient inclusion-At M12 (+/-15 days) : 12 months after patient inclusion |
| 4.2) The Pittsburgh sleep quality index (PSQI questionnaire) at 3, 6 and 12 months | At M3 (+/-15 days) : 3 months after patient inclusion-At M6 (+/-15 days) : 6 months after patient inclusion-At M12 (+/-15 days) : 12 months after patient inclusion |
| 5) Cost of health expenditure | The cost of health expenditure will be collected from inclusion to M12 (12 months after patient inclusion) |
Countries
France
Outcome results
None listed